#PFIZER News

FEED

Traws Pharma's ICAR Poster Highlights Potency of COVID-19 Candidate

benzinga.com NEWTOWN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. ("Traws" or "Traws Pharma"), a clinical stage biopharmaceutical company developing oral small molecules for…

Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027

benzinga.com Pfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5 billion by the end of 2027. What Happened: The new program builds on a…

Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks

finance.yahoo.com Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock in vaccine developers. It’s a familiar setup for industry veterans who have witnessed…

Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts

cnbc.com Exterior view of the Pfizer headquarters building in New York City on Jan. 29, 2023. Pfizer on Wednesday said it has launched a new multiyear program to reduce costs as it…

Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027

aol.com U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting…

Don’t Forget These 5 Passive Income Dividend Stocks With Yields as High as 8.4%

247wallst.com Investors love dividend stocks because they provide dependable income and give investors a great opportunity for solid total return. Total return includes interest, capital…

7 Safe-Haven Stocks to Weather Any Storm

investorplace.com Discover seven solid stocks with stability and progress in the healthcare, consumer staples, and discretionary sectors Investors often look to safe-haven equities for…

Cardano Founder Charles Hoskinson Accuses US Fed Of Corruption, Here’s Why

coingape.com Charles Hoskinson, the founder of Cardano (ADA), has openly accused the US Federal Reserve of “corruption.” This statement came in response the US Red’s latest move wherein…

1 Top Dividend Stock to Load Up On Now

finance.yahoo.com For nearly a century, dividends have been the silent workhorses of the stock market, consistently contributing to the bulk of U.S. stock returns. The data spanning 98 years…

3 Things You Need to Know If You Buy Novavax Today

finance.yahoo.com Novavax (NASDAQ: NVAX) stock has both soared and plummeted at times in recent years. Investors initially bet on the biotech company to be a winner in the coronavirus vaccine…

Pro-XRP Lawyer Declares ‘Corruption Era’ Amid New Evidence

bitcoinist.com Pro-XRP lawyer and Republican Party candidate for the Senate Massachusetts, John E. Deaton voiced severe criticisms of what he described as pervasive corruption within…

High salaries, poor performance: These were the most overpaid CEOs last year

fastcompany.com When it comes to CEO salaries, no one topped Broadcom’s Hock Tan last year. A new study by the Wall Street Journal ranks Tan (and his $161.74 million pay package) as the…

This overlooked obesity-drug stock has 80% upside, JPMorgan says

aol.com None Structure Therapeutics is an overlooked stock that could surge on the GLP-1 weight loss craze. • None JPMorgan initiated the company at "Overweight" with a $65 price…

3 Healthcare Stocks to Buy Now: May 2024

investorplace.com These healthcare stocks to buy should have dramatic upside in coming months and years It’s a great time to be looking at healthcare stocks to buy now. According to research…

GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims

benzinga.com GSK Plc GSK has been reportedly sued by an independent Connecticut laboratory, Valisure, accusing the pharmaceutical giant of defrauding the U.S. government and taxpayers by…

Will AstraZeneca be the UK’s first £200bn company?

theguardian.com The last time the AstraZeneca chief executive, Pascal Soriot, set long-term sales targets, he was greeted with a chorus of scepticism. It was 2014 and the company was…

Texas’ Ken Paxton in the mix for AG in a second Trump term

msnbc.com It’s a little early for Donald Trump to start making personnel plans for a possible second term. Election Day 2024 is still 167 days away, and while polling averages suggest…

3 Blue-Chip Stocks to Buy on the Dip: May 2024

investorplace.com Buy these discounted stocks to increase your portfolio's value Despite a recent slowdown, the future of the U.S. economy appears promising. Economists remain optimistic,…

Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?

finance.yahoo.com The past couple of years haven't been easy ones to be a Pfizer (NYSE: PFE) shareholder. The windfall profits its COVID-19 products produced in the early days of the pandemic…

AstraZeneca aims to nearly double revenues to $80bn by 2030

theguardian.com Britain’s biggest drugmaker, AstraZeneca, has set out a bold ambition to reach $80bn (£63bn) in revenues by 2030 from treatments for cancer, rare diseases and other…

Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now

finance.yahoo.com Stocks have been a wealth-creating machine for investors over the long run. Though other asset classes have delivered a positive nominal return to patient investors,…

How GSK CEO Emma Walmsley kept her job and turned a belligerent activist investor into an ally

fortune.com When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the…

HPV Vaccination May Trigger Rare And Often Misdiagnosed Autoimmune Brain Disease

zerohedge.com HPV Vaccination May Trigger Rare And Often Misdiagnosed Autoimmune Brain Disease Authored by Megan Redshaw, J.D. via The Epoch Times (emphasis ours), (Kateryna…

AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines

cnbc.com LONDON — Pharmaceutical company AstraZeneca on Tuesday said it planned to increase its total revenue to $80 billion by 2030 — up 75% from $45.8 billion in 2023. "We have a…

Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots

barrons.com After disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are hoping for an August rollout of an updated shot.

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute

benzinga.com A Delaware federal jury has determined that AstraZeneca Plc AZN must pay Pfizer Inc PFE $107.5 million in damages, concluding that AstraZeneca’s blockbuster lung cancer…

3 Blue-Chip Stocks Set to Triple Soon

investorplace.com Investors should have a wide range of companies in multiple sectors within their investment portfolio. But the backbone of any resilient portfolio that can withstand a bear…

6 Safe Blue Chip Dividend Stocks That Yield More Than Treasury Bonds

247wallst.com Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable…

Pfizer wins cancer drug patent case against AstraZeneca

finance.yahoo.com The US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer in damages for infringing patents related to the lung cancer drug…

3 High-Yield Dividend Stocks I'm Buying Hand Over Fist

finance.yahoo.com There are three main categories of investors: growth investors, income investors, and value investors. I'd classify myself as a mix of all three, except my focus is on…

3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now

finance.yahoo.com Investors looking to pad their passive income streams with high-yield dividend stocks have three excellent choices. If you have an extra $100 to invest, you could set…

This Stock Just More Than Doubled in 1 Day: Is It a Buy?

finance.yahoo.com Vaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months have been tough -- and management warned investors that the business might…

Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their Lead?

finance.yahoo.com Are you famous enough for picking great stocks to become a billionaire money manager? If not, then there's a lot you could learn from the handful of folks who have. It's…

Is Novavax Stock a Buy?

finance.yahoo.com Novavax (NASDAQ: NVAX) has been a highly volatile stock in recent years, and that volatility is on full display again this month. Shares of the healthcare stock are up 200%…

Ex-CDC Director Says It's High Time To Admit 'Significant Side Effects' Of COVID-19 Vaccines

zerohedge.com Ex-CDC Director Says It's High Time To Admit 'Significant Side Effects' Of COVID-19 Vaccines Authored by Tom Ozimek via The Epoch Times (emphasis ours), Dr. Robert Redfield,…

How the love story between von der Leyen and Pfizer turned sour

euronews.com From making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and flows in the love story between Ursula von der Leyen and big pharma Pfizer.…

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech

finance.yahoo.com Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with Pfizer Inc (NYSE:PFE) and…

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

aol.com AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its…

Moderna wins patent case in Europe against Pfizer, BioNTech over COVID shot

theglobeandmail.com Moderna has won a case at the European Patent Office against Pfizer and BioNTech in a dispute over its COVID-19 vaccine, the company said on Friday. Moderna said that the…

Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe

theglobeandmail.com Moderna MRNA-Q said on Friday the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing COVID-19 vaccine dispute with…

D1 Capital hikes its bet on this entertainment stock by more than 400%, shifts Big Tech holdings

cnbc.com Dan Sundheim's D1 Capital Partners raised its stake by more than 400% in a live entertainment stock during the first quarter, while reallocating funds across major…

Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot

aol.com May 17, 2024 at 11:00 AM (Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the company said…

Could Novavax Become the Next Moderna?

finance.yahoo.com Novavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their shares soared -- in fact,…

EU Commission Plans to Strip Funding From Public Prosecutors Investigating Ursula von der Leyen’s Pfizergate Scandal

nakedcapitalism.com As regular readers are well aware, EU Commission President Ursula von der Leyen is facing a number of legal challenges over the Pfizergate scandal, including from the New…

2 Top Growth Stocks Down 24% and 50% to Buy With $100

finance.yahoo.com The healthcare industry is full of opportunities for long-term investors to become part-owner in compelling businesses that are changing the future for patients across…

The Long Goodbye? Mitch McConnell and Big Money Politics

nakedcapitalism.com Yves here. As we’ve mentioned occasionally, storied short seller David Einhorn would often warn his team: “No matter how bad you think it is, it’s worse.” Here, even though…

GSK raises $1.5 billion from offloading Haleon stake at a discount

aol.com May 17, 2024 at 2:21 AM (Reuters) - GSK has raised 1.25 billion pounds ($1.52 billion) from selling its entire remaining stake in consumer healthcare firm Haleon, the…

Brooke Shields, Terry Crews, Katie Couric Added to Tribeca X Speakers Lineup

hollywoodreporter.com Brooke Shields, Terry Crews and Katie Couric are among the high-profile figures added as speakers for the Tribeca Festival‘s Tribeca X advertising and marketing section, now…

GSK intends to sell its remaining stake in Haleon

aol.com May 16, 2024 at 11:33 AM (Reuters) - British drugmaker GSK said on Thursday it plans to sell about 385 million shares, representing its entire shareholding, in spun-off…

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

benzinga.com On Sunday, Pfizer PFE and AstraZeneca Plc AZN were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations…

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs

investorplace.com AI continues to impact pharma stocks to buy in a major way It’s no secret that artificial intelligence (AI) promises to transform every industry and sector, pharma included.…

The Entire Business World on a Single Page. Free to Use →